Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For B5A.SW
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics n.A.
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio -4.21 1.26 1.32
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -80.99 -1.32 6.94
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value inf 0.00 4.59
Cash inf 0.00 0.64
Capex inf 0.00 -0.27
Free Cash Flow inf 0.00 -0.82
Revenue inf 0.00 4.28
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin 3.82 0.50 0.48
Operating Margin -62.84 0.04 0.10
ROA -37.04 < 0.005 < 0.005
ROE -38.23 < 0.005 < 0.005
ROIC -40.97 < 0.005 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of B5A.SW is permitted for members.
5 Growth
The "Growth Entry" for the Focus of B5A.SW is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of B5A.SW is permitted for members.